Search

Your search keyword '"Broijl, A"' showing total 5 results
Start Over Author "Broijl, A" Journal blood cancer journal
5 results on '"Broijl, A"'

1. Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands

Author

Mirian Brink, Monique C. Minnema, Otto Visser, Mark-David Levin, Eduardus F. M. Ward Posthuma, Annemiek Broijl, Pieter Sonneveld, Marjolein van der Klift, Wilfried W. H. Roeloffzen, Matthijs Westerman, Cleo R. van Rooijen, Paul A. F. Geerts, Sonja Zweegman, Niels W. C. J. van de Donk, and Avinash G. Dinmohamed

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published
2022
Full Text
View/download PDF

2. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study

Author

Mirian Brink, Kaz Groen, Pieter Sonneveld, Monique C. Minnema, Annemiek Broijl, Avinash G. Dinmohamed, Ellen van der Spek, Mark-David Levin, Paula F. Ypma, Esther de Waal, Eduardus F. M. Ward Posthuma, Sonja Zweegman, and Niels W. C. J. van de Donk

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Identification of risk factors for early mortality (EM) in multiple myeloma (MM) patients may contribute to different therapeutic approaches in patients at risk for EM. This population-based study aimed to assess trends in EM and risk factors for EM among MM patients diagnosed in the Netherlands. All MM patients, newly diagnosed between 1989 and 2018, were identified in the Netherlands Cancer Registry. Patients were categorized into three calendar periods (1989–1998, 1999–2008, 2009–2018) and into five age groups (≤65, 66–70, 71–75, 76–80, >80 years). EM was defined as death by any cause ≤180 days post-diagnosis. We included 28,328 MM patients (median age 70 years; 55% males). EM decreased from 22% for patients diagnosed in 1989–1998 to 13% for patients diagnosed in 2009–2018 (P 70 years. Therefore, novel strategies should be explored to improve the outcome of patients at risk for EM.

Published
2021
Full Text
View/download PDF

3. Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands

Author

Brink, Mirian, Minnema, Monique C., Visser, Otto, Levin, Mark-David, Posthuma, Eduardus F. M. Ward, Broijl, Annemiek, Sonneveld, Pieter, van der Klift, Marjolein, Roeloffzen, Wilfried W. H., Westerman, Matthijs, van Rooijen, Cleo R., Geerts, Paul A. F., Zweegman, Sonja, van de Donk, Niels W. C. J., and Dinmohamed, Avinash G.

Published
2022
Full Text
View/download PDF

5. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study

Author

Mark-David Levin, Paula F. Ypma, Sonja Zweegman, Monique C. Minnema, Pieter Sonneveld, Esther G. M. de Waal, Eduardus F. M. Posthuma, Mirian Brink, Kaz Groen, Niels W.C.J. van de Donk, Ellen van der Spek, Avinash G Dinmohamed, Annemiek Broijl, Hematology, Public Health, and CCA - Cancer Treatment and quality of life

Subjects
Adult, Male, medicine.medical_specialty, Population, MEDLINE, Newly diagnosed, Article, Age groups, SDG 3 - Good Health and Well-being, Internal medicine, Humans, Medicine, In patient, Registries, education, Multiple myeloma, RC254-282, Aged, Netherlands, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Age Factors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hematology, Middle Aged, medicine.disease, Prognosis, Cancer registry, Population based study, Oncology, Risk factors, Female, Multiple Myeloma, business, Follow-Up Studies
Abstract

Identification of risk factors for early mortality (EM) in multiple myeloma (MM) patients may contribute to different therapeutic approaches in patients at risk for EM. This population-based study aimed to assess trends in EM and risk factors for EM among MM patients diagnosed in the Netherlands. All MM patients, newly diagnosed between 1989 and 2018, were identified in the Netherlands Cancer Registry. Patients were categorized into three calendar periods (1989–1998, 1999–2008, 2009–2018) and into five age groups (≤65, 66–70, 71–75, 76–80, >80 years). EM was defined as death by any cause ≤180 days post-diagnosis. We included 28,328 MM patients (median age 70 years; 55% males). EM decreased from 22% for patients diagnosed in 1989–1998 to 13% for patients diagnosed in 2009–2018 (P 70 years. Therefore, novel strategies should be explored to improve the outcome of patients at risk for EM.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results